Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Sep 27, 2024 | 13.08 | +0.38 |
Absci | ABSI | Sep 27, 2024 | 3.97 | -3.41 |
ABVC Biopharma | ABVC | Sep 27, 2024 | 0.69 | +4.14 |
Ac Immune SA | ACIU | Sep 27, 2024 | 3.75 | +1.35 |
Acacia Research | ACTG | Sep 27, 2024 | 4.73 | -0.63 |
Academy Sports and Outdoors | ASO | Sep 27, 2024 | 59.19 | -0.55 |
Acadia Healthcare | ACHC | Sep 27, 2024 | 63.28 | -16.36 |
Acadia Pharmaceuticals | ACAD | Sep 27, 2024 | 15.69 | +1.36 |
Acadia Realty Trust | AKR | Sep 27, 2024 | 23.16 | +0.78 |
Acasti Pharma A | ACST | Sep 27, 2024 | 3.12 | +1.63 |
Accel Entertainment | ACEL | Sep 27, 2024 | 11.57 | +0.35 |
Accelerate Diagnostics | AXDX | Sep 27, 2024 | 1.76 | +3.53 |
Accenture A | ACN | Sep 27, 2024 | 349.70 | -1.72 |
Acco Brands | ACCO | Sep 27, 2024 | 5.41 | +0.74 |
Accolade | ACCD | Sep 27, 2024 | 3.86 | 0.00 |
Accuray | ARAY | Sep 27, 2024 | 1.79 | +2.29 |
Acelyrin | SLRN | Sep 27, 2024 | 4.93 | +1.02 |
Achieve Life Sciences | ACHV | Sep 27, 2024 | 4.77 | +7.43 |
Achilles Therapeutics ADR | ACHL | Sep 27, 2024 | 1.01 | +3.35 |
ACI Worldwide | ACIW | Sep 27, 2024 | 50.23 | +1.54 |
Aclarion | ACON | Sep 27, 2024 | 0.18 | +0.40 |
Aclaris Therapeutics | ACRS | Sep 27, 2024 | 1.17 | -0.85 |
ACM Research A | ACMR | Sep 27, 2024 | 19.49 | +0.96 |
Acme United | ACU | Sep 27, 2024 | 40.35 | -3.52 |
ACNB | ACNB | Sep 27, 2024 | 43.18 | +3.25 |
ACRES Commercial Realty | ACR | Sep 27, 2024 | 15.53 | -0.51 |
ACRES Commercial Realty C Pref | ACR-C | Sep 27, 2024 | 25.27 | +0.26 |
ACRES Commercial Realty D Pref | ACR-D | Sep 27, 2024 | 23.39 | 0.00 |
Acri Capital Acquisition Unit | ACACU | Sep 27, 2024 | 12.94 | 0.00 |
Acrivon Therapeutics | ACRV | Sep 27, 2024 | 7.16 | -1.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.